Publications by authors named "Minden Collamore"

Claim this Profile
P
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Elaine T Lam, Matthew D Ringel, Richard T Kloos, Thomas W Prior, Michael V Knopp, Minden Collamore

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of sorafenib in metastatic thyroid cancer.
Richard T Kloos, Matthew D Ringel, Michael V Knopp, Nathan C Hall, Mark King, Minden Collamore

J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G3139 (Genasense) in patients with advanced merkel cell carcinoma.
Manisha H Shah, Kimberly A Varker, Minden Collamore, James A Zwiebel, Daniel Coit

Am J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma.
Jennifer A Woyach, Richard T Kloos, Matthew D Ringel, Daria Arbogast, Minden Collamore

J Clin Endocrinol Metab· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors.
Manisha H Shah, Philip Binkley, Kenneth Chan, Jim Xiao, Daria Arbogast, Minden Collamore

Clin Cancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p42/44 mitogen-activated protein kinase pathway couples photic input to circadian clock entrainment.
Greg Q Butcher, Jeff Doner, Heather Dziema, Minden Collamore, Penny W Burgoon

J Biol Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis